Market Cap

Liquidia Corp Market Capitalization:

€1.12 Billion

EUR as of Jan. 1, 2025

US$1.17 Billion

business Liquidia Corp Company Profile

Liquidia Corp Main Stock Listing

FSX: LT4

Market Capitalization History of Liquidia Corp

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $113.24 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $76.33 B
Marinomed Biotech AG $56.13 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $689.42 B
Novo Nordisk $622.07 B
UnitedHealth Group $487.54 B
Johnson & Johnson $353.05 B
AbbVie $301.60 B

Yearly evolution of Liquidia Corp market cap

Date Market Cap YoY Change
Jan. 1, 2025 €1.12 B 46.21%
Jan. 1, 2024 €768.8 M 92.01%
Jan. 1, 2023 €400.4 M 20.68%
Jan. 1, 2022 €331.8 M 109.57%
Jan. 1, 2021 €158.3 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +327.04%

$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Liquidia Corp Categories

United States languages Healthcare languages Biotechnology
United States Healthcare United States Biotechnology

Stocks & Indices

Liquidia Corp has the following listings and related stock indices.


Stock: FSX: LT4

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.